I completed my BSc in Biotechnology at Universidad Politécnica de Madrid, and furthered my academic journey with a traineeship in the GlowLab Laboratory for Regenerative Neuroscience at the University of Zagreb School of Medicine. During my tenure in the Research Master in Cognitive and Clinical Neuroscience at Maastricht University, I cultivated a profound interest in the neurobiological and cognitive effects that psychedelic drugs exert. Awarded with the atai fellowship, I am currently working at the Center for the Neuroscience of Psychedelics at Mass General Hospital, Harvard Medical School, advancing my expertise in preclinical research methods within fundamental neuroscience. My focus includes exploring the neurobiological effects of both natural and synthetic psychedelics, alongside other neuroplasticity modulators.
Additionally, I engage in diverse roles within foundations and associations, serving as a scientific advisor for InAwe, as an author and copywriter for OPEN Foundation's newsletter, and contributing to the organization of conferences such as the 2021 and 2024 ICPRs (Interdisciplinary Conference on Psychedelic Research) and the 2020 EBPS (European Behavioural Pharmacology Society) biennial meeting.